207 related articles for article (PubMed ID: 25630571)
1. Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D and Central Activation of Codeine to Morphine.
McMillan DM; Tyndale RF
Neuropsychopharmacology; 2015 Jun; 40(7):1804-12. PubMed ID: 25630571
[TBL] [Abstract][Full Text] [Related]
2. Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response.
McMillan DM; Tyndale RF
Biochem Pharmacol; 2017 Dec; 145():158-168. PubMed ID: 28837793
[TBL] [Abstract][Full Text] [Related]
3. First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo.
Zhou K; Khokhar JY; Zhao B; Tyndale RF
Biochem Pharmacol; 2013 Jun; 85(12):1848-55. PubMed ID: 23623752
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol with propranolol and nicotine.
Wang Q; Han X; Li J; Gao X; Wang Y; Liu M; Dong G; Yue J
Xenobiotica; 2015 Apr; 45(4):335-44. PubMed ID: 25387586
[TBL] [Abstract][Full Text] [Related]
5. Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia.
McMillan DM; Miksys S; Tyndale RF
Addict Biol; 2019 Mar; 24(2):228-238. PubMed ID: 29266563
[TBL] [Abstract][Full Text] [Related]
6. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.
Yue J; Miksys S; Hoffmann E; Tyndale RF
J Psychiatry Neurosci; 2008 Jan; 33(1):54-63. PubMed ID: 18197273
[TBL] [Abstract][Full Text] [Related]
7. Centrally administered CYP2D inhibitors increase oral tramadol analgesia in rats.
McMillan DM; El-Sherbeni AA; Richards J; Tyndale RF
Brain Res Bull; 2020 Nov; 164():400-406. PubMed ID: 32926950
[TBL] [Abstract][Full Text] [Related]
8. CYP2D in the brain impacts oral hydrocodone analgesia in vivo.
Richards J; Miksys S; Novalen M; Tyndale RF
Neuropharmacology; 2022 Dec; 221():109291. PubMed ID: 36241086
[TBL] [Abstract][Full Text] [Related]
9. Sex, estrous cycle, and hormone regulation of CYP2D in the brain alters oxycodone metabolism and analgesia.
Arguelles N; Richards J; El-Sherbeni AA; Miksys S; Tyndale RF
Biochem Pharmacol; 2022 Apr; 198():114949. PubMed ID: 35143755
[TBL] [Abstract][Full Text] [Related]
10. Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys.
Miller RT; Miksys S; Hoffmann E; Tyndale RF
Br J Pharmacol; 2014 Jun; 171(12):3077-88. PubMed ID: 24611668
[TBL] [Abstract][Full Text] [Related]
11. Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms.
Miksys S; Wadji FB; Tolledo EC; Remington G; Nobrega JN; Tyndale RF
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():140-148. PubMed ID: 28454738
[TBL] [Abstract][Full Text] [Related]
12. Rat brain CYP2B induction by nicotine is persistent and does not involve nicotinic acetylcholine receptors.
Khokhar JY; Miksys SL; Tyndale RF
Brain Res; 2010 Aug; 1348():1-9. PubMed ID: 20599831
[TBL] [Abstract][Full Text] [Related]
13. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
Mellon RD; Bayer BM
J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
[TBL] [Abstract][Full Text] [Related]
14. Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.
Mann A; Miksys S; Lee A; Mash DC; Tyndale RF
Neuropharmacology; 2008 Dec; 55(7):1147-55. PubMed ID: 18687346
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological relationship between nicotinic and opioid systems in analgesia and corticosterone elevation.
Yamamoto A; Kiguchi N; Kobayashi Y; Maeda T; Ueno K; Yamamoto C; Kishioka S
Life Sci; 2011 Dec; 89(25-26):956-61. PubMed ID: 22036617
[TBL] [Abstract][Full Text] [Related]
16. The possible cross-tolerance between morphine- and nicotine-induced hypothermia in mice.
Zarrindast MR; Barghi-Lashkari S; Shafizadeh M
Pharmacol Biochem Behav; 2001 Feb; 68(2):283-9. PubMed ID: 11267633
[TBL] [Abstract][Full Text] [Related]
17. Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia.
Tirgar F; Rezayof A; Zarrindast MR
Neuroscience; 2014 Sep; 277():392-402. PubMed ID: 25050820
[TBL] [Abstract][Full Text] [Related]
18. The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model.
Cleary J; Mikus G; Somogyi A; Bochner F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1528-34. PubMed ID: 7996467
[TBL] [Abstract][Full Text] [Related]
19. Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects.
Khokhar JY; Tyndale RF
Neuropsychopharmacology; 2011 Feb; 36(3):692-700. PubMed ID: 21107310
[TBL] [Abstract][Full Text] [Related]
20. Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA.
Vihavainen T; Relander TR; Leiviskä R; Airavaara M; Tuominen RK; Ahtee L; Piepponen TP
J Neurochem; 2008 Nov; 107(3):844-54. PubMed ID: 18786163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
